Eiko Lifesciences Limited Q1 FY2023 net profit at Rs. 8.28 lakhs

Narendra Investments (Delhi) Ltd has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 3.2756 crores during the period ended June 30, 2022 as compared to Rs. 5.4972 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.0828 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 0.1469 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.10 for the period ended June 30, 2022 as compared to Rs. 0.18 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 3.2756 crs	₹5.4972 crs	-40.41%
Net Profit	₹0.0828 crs	₹0.1469 crs	-43.64%
EPS	₹0.10	₹0.18	-44.44%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 3.2756 crores during the period ended June 30, 2022 as compared to Rs.8.5719 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.0828 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.4051 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.10 for the period ended June 30, 2022 as compared to Rs.0.64 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 3.2756 crs	₹8.5719 crs	-61.79%
Net Profit	₹0.0828 crs	₹0.4051 crs	-79.56%
EPS	₹0.10	₹0.64	-84.38%

Shares of Narendra Investments (Delhi) Ltd was last trading in BSE at Rs. 39.40 as compared to the previous close of Rs. 41.80. The total number of shares traded during the day was 9594 in over 51 trades.

The stock hit an intraday high of Rs. 42.10 and intraday low of 38.10. The net turnover during the day was Rs. 381291.00.

Source : Equity Bulls

Keywords

EikoLifesciences Q1FY23 ResultUpdate